Shijiazhuang Pharmaceutical Group

National innovative enterprise, the first pharmaceutical constituent stock of HSI

Stock code

Shijiazhuang Pharmaceutical Holding Group Co., Ltd

Shijiazhuang Pharmaceutical Holding Group Co., Ltd. is a national innovative enterprise integrating R&D, production and sales of innovative drugs. The Group has total assets of 68 billion yuan and 28000 employees. The Group has a listed company in Hong Kong shares and A-shares, and the listed company in Hong Kong (01093. HK) is a constituent stock of the Hang Seng Index.

details

ten +

Drug production base
110+ +

Product sales country or region
three hundred +

Products under development

News Center

MORE >

Scientific research and development

internationalization

Leading Chinese pharmaceutical enterprises to go abroad is one of the development visions of Shijiazhuang Pharmaceutical Group, and the innovation strategy has also been deeply extended in the internationalization process of Shijiazhuang Pharmaceutical Group. At present, Shijiazhuang Pharmaceutical Group has established an integrated R&D system at home and abroad, and its products have spread to more than 110 countries or regions around the world.

Product Center